BBI Solutions announces the launch of ten infectious disease markers, three inflammatory markers, two fertility markers, and one cardiac marker. All the antibodies have been tested in either lateral flow or ELISA, are available for sampling, and many are already being used in commercial assays. BBI’s new infectious disease markers include H. pylori, Influenza A and B, E. coli O157, and Campylobacter and Legionella pneumophila. BBI also released antibodies for three inflammatory markers (Calprotectin, CRP, and IL-6) two fertility markers (AMH and Estriol), and Myoglobin antibodies as a cardiac marker. There are a number of recommended matched pairs, which will help save time and money in screening processes.